Studies

Showing 26 studies.

P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age

DAIDS Number

Research Area

Study Status

P1071: CCR5 Vicriviroc (SCH-417690)

DAIDS Number

Research Area

Study Status

P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity

DAIDS Number

Research Area

Study Status

P1061s: Evaluation of Immunologic Mememory in HIV-Infected Children Treated with HAART.

DAIDS Number

Research Area

Study Status

P1059: Phase I Trial of Recombinant Vaccines in HIV+ Young Adults

DAIDS Number

Research Area

Study Status

P1051: Pharmacokinetic Study of Tipranavir with Ritonavir in HIV-infected Patients.

DAIDS Number

Research Area

Study Status

P1038: Safety of High Dose Lopinavir/Ritonavir with and without Saquinavir

DAIDS Number

Research Area

Study Status

P1024: Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine

DAIDS Number

Research Area

Study Status

P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents

DAIDS Number

Research Area

Study Status

P1017: PEG-Intron in HIV+Children

DAIDS Number

Research Area

Study Status